Cargando…

Randomized clinical trials to identify optimal antibiotic treatment duration

BACKGROUND: Antibiotic resistance is a major barrier to the continued success of antibiotic treatment. Such resistance is often generated by overly long durations of antibiotic treatment. A barrier to identifying the shortest effective treatment duration is the cost of the sequence of clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horsburgh, C Robert, Shea, Kimberly M, Phillips, Patrick, LaValley, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622584/ https://www.ncbi.nlm.nih.gov/pubmed/23536969 http://dx.doi.org/10.1186/1745-6215-14-88

Ejemplares similares

Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2018)

Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trials
por: Reichmann, William M, et al.
Publicado: (2013)

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
por: Ananthakrishnan, Revathi, et al.
Publicado: (2019)

Optimising trial designs to identify appropriate antibiotic treatment durations
por: Pouwels, Koen B., et al.
Publicado: (2019)

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
por: Lowe, Leroy, et al.
Publicado: (2022)

The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
por: Felson, David T, et al.
Publicado: (2014)

Prognostic Outcomes of Tall Cell Variant Papillary Thyroid Cancer: A Meta-Analysis
por: Jalisi, Scharukh, et al.
Publicado: (2010)

Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials
por: Imperial, Marjorie Z., et al.
Publicado: (2021)

Provider-Identified Deprescribing Facilitators and Strategies for Older Adults in Primary Care: A Team Alice Study
por: Brady, Laura, et al.
Publicado: (2020)

An overview of the BOIN design and its current extensions for novel early-phase oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2022)

Strategies for conducting health research with Latinos during times of political incivility
por: Sage, Rayna, et al.
Publicado: (2018)

Reply
por: Felson, David, et al.
Publicado: (2022)

Deciphering the Signal From the Noise: Caregivers’ Information Appraisal and Credibility Assessment of Cancer-Related Information Exchanged on Social Networking Sites
por: Gage-Bouchard, Elizabeth A., et al.
Publicado: (2019)

Quadriceps Strength After Anterior Cruciate Ligament Reconstruction Compared With Uninjured Matched Controls: A Systematic Review and Meta-analysis
por: Brown, Conlan, et al.
Publicado: (2021)

Reexamining remission definitions in rheumatoid arthritis: considering the twenty-eight–joint Disease Activity Score, C-reactive protein level and patient global assessment
por: Felson, David, et al.
Publicado: (2021)

Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C‐Reactive Protein, and Patient Global Assessment
por: Felson, David T., et al.
Publicado: (2021)

Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis
por: Bujor, Andreea M., et al.
Publicado: (2019)

Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa
por: Kluberg, Sheryl A., et al.
Publicado: (2018)

Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder
por: Hausman-Cohen, Sharon, et al.
Publicado: (2022)

Comparative analysis of the growth and biological activity of a respiratory and atheroma isolate of Chlamydia pneumoniae reveals strain-dependent differences in inflammatory activity and innate immune evasion
por: He, Xianbao, et al.
Publicado: (2015)

Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
por: Ananthakrishnan, Revathi, et al.
Publicado: (2016)

PTT Advisor: A CDC-supported initiative to develop a mobile clinical laboratory decision support application for the iOS platform
por: Savel, Thomas G., et al.
Publicado: (2013)

Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis
por: Furukawa, Yuki, et al.
Publicado: (2023)

Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective randomized multicenter trial
por: Gagliardi, G., et al.
Publicado: (2010)

The index ‘Treatment Duration Control’ for enabling randomized controlled trials with variation in duration of treatment of chronic pain patients
por: van der Glas, Hilbert W, et al.
Publicado: (2013)

Shortening antibiotic duration in the treatment of acute cholangitis: rationale and study protocol for an open-label randomized controlled trial
por: Iwata, Kentaro, et al.
Publicado: (2020)

Impact of reduced antibiotic treatment duration on antimicrobial resistance in critically ill patients in the randomized controlled SAPS-trial
por: Shajiei, Arezoo, et al.
Publicado: (2023)

Development of a clinical prediction algorithm for knee osteoarthritis structural progression in a cohort study: value of adding measurement of subchondral bone density
por: LaValley, Michael P., et al.
Publicado: (2017)

The Optimal Hemostasis Duration After Tooth Extraction: A Randomized Controlled Trial
por: Yerragudi, Navaneeth, et al.
Publicado: (2023)

Duration of Intrapartum Antibiotics for Group B Streptococcus on the Diagnosis of Clinical Neonatal Sepsis
por: Turrentine, Mark A., et al.
Publicado: (2013)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis
por: Useem, Johanna, et al.
Publicado: (2015)

Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
por: Sangani, Ruchika A., et al.
Publicado: (2022)

1192. Validation of an Electronic Dashboard in Identifying Excess Duration of Antibiotics for Pneumonia
por: Ferranti, Mary, et al.
Publicado: (2023)

Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial
por: Mo, Yin, et al.
Publicado: (2021)

Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial
por: Jeon, Kyeongman, et al.
Publicado: (2019)

Increasing the power of randomized trials comparing different treatment durations
por: Ouyang, Yongdong, et al.
Publicado: (2020)

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
por: Hochreiter, Marcel, et al.
Publicado: (2009)

Rethinking non-inferiority: a practical trial design for optimising treatment duration
por: Quartagno, Matteo, et al.
Publicado: (2018)

Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study
por: Ngwa, Julius S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dojko9mt6n718aa8f1lm65om3o